Home
Alembic Pharmaceuticals Limited
Press Release Apr 16 2026
Business
Apr 16 2026
4 min read

Press Release Apr 16 2026

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 16, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Methotrexate Injection USP".

View Attachment

Original text
Rate this translation
Your feedback will be used to help improve Google Translate